Register Login
Register to leave comments
  • News bot Aug. 13, 2026, 8:10 p.m.

    📋 4D MOLECULAR THERAPEUTICS, INC. (FDMT) - Financial Results

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 16:06:44

    Event Type: Financial Results

    Event Details:

    4D MOLECULAR THERAPEUTICS, INC. (FDMT) Reports the reporting period Financial Results 4D MOLECULAR THERAPEUTICS, INC. (FDMT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 3781
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 430629
      • expected in Q3 2026
      • expected in Q4 2026
      • expected in Q2 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 59.46K 150.65K $-91.19K -60.53%
    Operating Expenses Other Income Net 4.80K 8.95K $-4.15K -46.39%
    Operating Expenses Net Loss 54.66K 141.70K $-87.04K -61.43%
    Operating Expenses Net Loss Per Share 0.98 2.05 $-1.07 -52.20%
    Operating Expenses Weighted Average Shares 55.93M 69.18M $-13.25M -19.15%
    Cash Equivalents Marketable Securities 430.63K 514.03K $-83.41K -16.23%
    Revenue 3.78K 15.00 $3.77K +25106.67%
    Loss from Operations 77.03K 59.46K $17.57K +29.55%
    Other Income, Net 4.09K 4.80K $-709.00 -14.78%
    Net Loss 72.94K 54.66K $18.28K +33.44%
    Cash and Marketable Securities 430.63K 514.03K $-83.41K -16.23%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: 4D MOLECULAR THERAPEUTICS, INC.
    • Ticker Symbol: FDMT

Search

News categories